1 / 22

TRITON-TIMI 38

TRITON-TIMI 38: Objective. To test the hypothesis that in ACS patients scheduled for PCI, the use of prasugrel reduces ischemic events as compared to clopidogrel.. 2. Wiviott, SD, et al. N Engl J Med 2007;357:2001-15.. TRITON-TIMI 38. Prasugrel60 mg LD, 10 mg/day. Clopidogrel300 mg LD, 75 mg/day

alton
Télécharger la présentation

TRITON-TIMI 38

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. TRITON-TIMI 38 Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel– Thrombolysis in Myocardial Infarction 1

    2. TRITON-TIMI 38: Objective To test the hypothesis that in ACS patients scheduled for PCI, the use of prasugrel reduces ischemic events as compared to clopidogrel. 2

More Related